OR WAIT 15 SECS
Notal Vision has sold its clinic-based preferential hyperacuity perimeter (Foresee PHP) business to Reichert Ophthalmic Instruments.
-Notal Vision has sold its clinic-based preferential hyperacuity perimeter (Foresee PHP) business to Reichert Ophthalmic Instruments.
Notal Vision sold the professional visual field analyzer, according to the company, so that it could fully invest its time and resources in its home-based PHP device, which the company previewed at the recent annual meeting of the American Academy of Ophthalmology and expects to launch in 2010. Sightpath Medical, previous distributor of the clinic-based PHP instrument, will distribute the home-based PHP device.
“Sightpath Medical and Reichert are working together to ensure a smooth transition for our [professional] PHP customers,” said Jim Tiffany, president and chief operating officer of TLCVision Corp. and its Sightpath Medical subsidiary. Reichert will assume responsibility as the warranty and service provider for all new clinic-based customers immediately and will begin servicing pre-existing customers Nov. 16.
Notal Vision invented the PHP technology in 2001 to assist in monitoring patients for the conversion from dry to wet age-related macular degeneration (AMD). The technology is the basis of both the clinic-based PHP and the home-based PHP, which will aim to help patients with AMD monitor the condition daily in their homes.